Favipiravir
Please read and agree to the disclaimer before watching this video.
. Glenmark's FabiFlu approved for coronavirus treatment in India, costs Rs 103 per tablet
Mumbai-based Glenmark Pharmaceuticals have launched a new antiviral drug - Favipiravir with brand name FabiFlu - for the treatment of mild to moderate Covid-19 patients. The firm has become the first Indian company to commercially launch the antiviral drug.
https://www.indiatoday.in/india/story/coronavirus-treatment-drug-glenmark-fabiflu-favipiravir-launch-india-rs-103-per-tablet-reduce-viral-load-1691066-2020-06-20
Coronavirus replication
https://www.ncbi.nlm.nih.gov/books/NBK554776/figure/article-52171.image.f1/
RdRp is the main enzyme of transcription-replication complex
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2322833/
Favipiravir mechanism of action and its study
https://www.biorxiv.org/content/10.1101/2020.05.15.098731v1.full.pdf+html
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
https://www.sciencedirect.com/science/article/pii/S2095809920300631?via%3Dihub
Potential coronavirus drug approved for marketing
Favipiravir, an antiviral that has shown potential in treating the novel coronavirus, was approved for marketing, the Taizhou government of Zhejiang province announced Sunday.
https://www.chinadaily.com.cn/a/202002/17/WS5e49efc2a310128217277fa3.html
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Therapeutic options in response to the 2019-nCoV outbreak are urgently needed. Here, we discuss the potential for repurposing existing antiviral agents to treat 2019-nCoV infection (now known as COVID-19), some of which are already moving into clinical trials.
https://www.nature.com/articles/d41573-020-00016-0
Fujifilm Announces the Start of a Phase III Clinical Trial of Influenza Antiviral Drug Avigan (favipiravir) on COVID-19 in Japan and Commits to Increasing Production
https://www.drugs.com/clinical_trials/fujifilm-announces-start-phase-iii-clinical-trial-influenza-antiviral-avigan-favipiravir-covid-19-18505.html ...
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. ...
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
Видео Favipiravir канала Drbeen Medical Lectures
. Glenmark's FabiFlu approved for coronavirus treatment in India, costs Rs 103 per tablet
Mumbai-based Glenmark Pharmaceuticals have launched a new antiviral drug - Favipiravir with brand name FabiFlu - for the treatment of mild to moderate Covid-19 patients. The firm has become the first Indian company to commercially launch the antiviral drug.
https://www.indiatoday.in/india/story/coronavirus-treatment-drug-glenmark-fabiflu-favipiravir-launch-india-rs-103-per-tablet-reduce-viral-load-1691066-2020-06-20
Coronavirus replication
https://www.ncbi.nlm.nih.gov/books/NBK554776/figure/article-52171.image.f1/
RdRp is the main enzyme of transcription-replication complex
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2322833/
Favipiravir mechanism of action and its study
https://www.biorxiv.org/content/10.1101/2020.05.15.098731v1.full.pdf+html
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
https://www.sciencedirect.com/science/article/pii/S2095809920300631?via%3Dihub
Potential coronavirus drug approved for marketing
Favipiravir, an antiviral that has shown potential in treating the novel coronavirus, was approved for marketing, the Taizhou government of Zhejiang province announced Sunday.
https://www.chinadaily.com.cn/a/202002/17/WS5e49efc2a310128217277fa3.html
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Therapeutic options in response to the 2019-nCoV outbreak are urgently needed. Here, we discuss the potential for repurposing existing antiviral agents to treat 2019-nCoV infection (now known as COVID-19), some of which are already moving into clinical trials.
https://www.nature.com/articles/d41573-020-00016-0
Fujifilm Announces the Start of a Phase III Clinical Trial of Influenza Antiviral Drug Avigan (favipiravir) on COVID-19 in Japan and Commits to Increasing Production
https://www.drugs.com/clinical_trials/fujifilm-announces-start-phase-iii-clinical-trial-influenza-antiviral-avigan-favipiravir-covid-19-18505.html ...
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. ...
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
Видео Favipiravir канала Drbeen Medical Lectures
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Remdesivir नहीं है Corona का इलाज, फिर Doctor क्यों मंगा रहे हैं ये दवाई?| Covid 19Covid 19 Cure - Dexamethasone World's first life saving Coronavirus drug, Current Affairs 2020 #UPSC18 COVID Autopsies - This is what they found in the Brain 😱Unvaccinated vs Vaccinated PROTECTION from COVID - Qatari Cohort | New StudiesCOVID-19 Vaccines: MODERNA | PFIZER/BIONTECH | ASTRAZENECACoronavirus Pandemic Update 87: More on Dexamethasone; Do COVID-19 antibodies last?Will Remdesivir Save The World From COVID?Coronavirus Pandemic Update 71: New Data on Adding Zinc to Hydroxychloroquine + Azithromycin#improveoxygenathome #stronglungs Treatment of COVID 19 ( Complete Lecture)Update of clinical featuresHigh Dose Thiamine And Cytokine StormCOVID-19 Day by Day Symptoms Timeline: My First Seven Days of Coronavirus Symptoms | COVID SymptomsThird Patient Interview with Shaun Barcavage - Neurological Issues After VaccinationHow Spike Protein Damages MitochondriaWho Loves Dr. Been The 4th Time Around?Covid 19 testing at home | How to test coronavirus at home?NAC N-AcetylcysteineEarly Treatment with GABA Reduces SEVERE COVID and Deaths in Mice (Study)Hypertension | Blood Pressure Regulation | Hypotension | Dr Najeeb LecturesSpike Protein Destroys Mitochondria (Studies)